Organism name | Myroxylon peruiferum |
---|---|
Genus | Myroxylon |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Myroxylon peruiferum |
---|---|
Linked NCBI taxonomy ID | 1231556 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00002579
![]() |
Texasin
/ 6,7-Dihydroxy-4'-methoxyisoflavone |
CHEMBL239028
|
3 / 2 / 0 | No. 3 | No. 15 |
![]() |
||
C00002510
![]() |
Olmelin
/ Pratensol / Biochanin A / Genistein 4'-methyl ether / 5,7-Dihydroxy-4'-methoxyisoflavone |
CHEMBL131921
|
C004541
|
51 / 65 / 83 | 64 / 2 | No. 3 | No. 15 |
![]() |
C00002507
![]() |
Castanin
/ Afromosin / Afrormosin / 7-Hydroxy-6,4'-dimethoxyisoflavone |
CHEMBL464404
|
C080240
|
7 / 14 / 39 | 1 / 0 | No. 35 | No. 15 |
![]() |
C00009405
![]() |
Cabreuvin
/ 7,3',4'-Trimethoxyisoflavone |
CHEMBL273891
|
7 / 10 / 6 | No. 35 | No. 15 |
![]() |
||
C00009414
![]() |
2'-Hydroxy-7,3',4'-trimethoxyisoflavone
|
No. 35 | No. 15 |
![]() |
||||
C00002547
![]() |
(-)-Medicarpin
/ 3-Hydroxy-9-methoxypterocarpan |
CHEMBL238845
CHEMBL413297 |
C047353
|
3 / 1 / 1 | No. 66 | No. 15 |
![]() |
|
C00009625
![]() |
4-Methoxyhomopterocarpin
|
No. 66 | No. 15 |
![]() |
||||
C00004579
![]() |
Fisetin
/ 3,3',4',7-Tetrahydroxyflavone / 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one |
CHEMBL31574
|
C017875
|
53 / 51 / 73 | 37 / 2 | No. 71 | No. 15 |
![]() |
C00009546
![]() |
3'-Methoxyisosativanone
|
No. 106 | No. 14 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002510 C00002547 C00009405 | 1 / 1 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00002507 C00002510 C00009405 | 4 / 2 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00002510 C00002579 C00004579 | 2 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002510 C00004579 C00009405 | 4 / 3 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002507 C00002510 C00004579 | 7 / 37 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00002507 C00002510 C00009405 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002507 C00002510 C00002547 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00002507 C00002510 C00009405 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002510 C00004579 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002510 C00004579 | 0 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00002510 C00004579 | 11 / 10 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002579 C00004579 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002510 C00004579 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002510 C00004579 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00002510 C00004579 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002510 C00004579 | 2 / 2 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00002510 C00004579 | 2 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002510 C00004579 | 0 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002510 C00004579 | 3 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002510 C00004579 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002510 C00004579 | 2 / 5 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002510 C00004579 | 0 / 1 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002510 C00009405 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002510 C00004579 | 1 / 2 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00002579 C00004579 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002510 C00004579 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00002510 C00009405 | 1 / 1 |
P10275 | Androgen receptor | NR3C4 | C00002510 C00004579 | 3 / 4 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00002510 | 0 / 0 |
P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | C00002510 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002507 | 2 / 2 |
P68871 | Hemoglobin subunit beta | Secreted protein | C00004579 | 4 / 4 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00004579 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00004579 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00004579 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002510 | 0 / 1 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002510 | 1 / 2 |
P11387 | DNA topoisomerase 1 | Isomerase | C00004579 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002510 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002510 | 1 / 8 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00002510 | 2 / 2 |
P06276 | Cholinesterase | Hydrolase | C00004579 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00004579 | 0 / 0 |
O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | C00002510 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004579 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004579 | 0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00004579 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002510 | 1 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00002510 | 1 / 0 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004579 | 1 / 0 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002510 | 1 / 1 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00004579 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002510 | 1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00004579 | 1 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00004579 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00004579 | 1 / 1 |
P55210 | Caspase-7 | C14 | C00004579 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002510 | 1 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00002510 | 0 / 0 |
Q92793 | CREB-binding protein | Enzyme | C00004579 | 1 / 1 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00004579 | 2 / 1 |
P29466 | Caspase-1 | C14 | C00004579 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00004579 | 5 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00002510 | 6 / 4 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00004579 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002547 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00004579 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00004579 | 0 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00004579 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00004579 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002510 | 4 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00004579 | 3 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002510 | 3 / 3 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00002507 | 1 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00002510 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00002510 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004579 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004579 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004579 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004579 | 0 / 0 |
Q00653 | Nuclear factor NF-kappa-B p100 subunit | Transcription Factor | C00002510 | 0 / 0 |
Q04206 | Transcription factor p65 | Transcription Factor | C00002510 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002510 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004579 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00004579 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00002510 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002510 | 1 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002510 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002507
C00002510
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00002510
C00004579
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002510
C00004579
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002510
C00004579
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002510
C00004579
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00002510
C00004579
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002510
C00004579
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002510
C00004579
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002510
C00004579
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002510
C00004579
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002510
C00004579
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00004579
|
1152 | CKB, B-CK, CKBB | creatine kinase, brain (EC:2.7.3.2) |
C00002510
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002510
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002510
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002510
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002510
|
1594 | CYP27B1, CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR, VDD1, VDDR, VDDRI, VDR | cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) |
C00002510
|
51071 | DERA, DEOC | deoxyribose-phosphate aldolase (putative) (EC:4.1.2.4) |
C00002510
|
1983 | EIF5, EIF-5, EIF-5A | eukaryotic translation initiation factor 5 |
C00002510
|
59084 | ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
C00002510
|
2060 | EPS15, AF-1P, AF1P, MLLT5 | epidermal growth factor receptor pathway substrate 15 |
C00002510
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00002510
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00002510
|
2101 | ESRRA, ERR1, ERRa, ERRalpha, ESRL1, NR3B1 | estrogen-related receptor alpha |
C00002510
|
2103 | ESRRB, DFNB35, ERR2, ERRb, ESRL2, NR3B2 | estrogen-related receptor beta |
C00002510
|
2104 | ESRRG, ERR3, ERRgamma, NR3B3 | estrogen-related receptor gamma |
C00002510
|
2091 | FBL, FIB, FLRN, RNU3IP1 | fibrillarin |
C00002510
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00002510
|
2760 | GM2A, GM2-AP, SAP-3 | GM2 ganglioside activator |
C00002510
|
2773 | GNAI3, 87U6, ARCND1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
C00002510
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00002510
|
9766 | KIAA0247 |
C00002510
|
|
753 | LDLRAD4, C18orf1 | low density lipoprotein receptor class A domain containing 4 |
C00002510
|
56925 | LXN, ECI, TCI | latexin |
C00002510
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00002510
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002510
|
9577 | BRE, BRCC4, BRCC45 | brain and reproductive organ-expressed (TNFRSF1A modulator) |
C00002510
|
4502 | MT2A, MT2 | metallothionein 2A |
C00002510
|
4698 | NDUFA5, B13, CI-13KD-B, CI-13kB, NUFM, UQOR13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (EC:1.6.5.3 1.6.99.3) |
C00002510
|
4841 | NONO, NMT55, NRB54, P54, P54NRB | non-POU domain containing, octamer-binding |
C00002510
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00002510
|
5204 | PFDN5, MM-1, MM1, PFD5 | prefoldin subunit 5 |
C00002510
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002510
|
5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor |
C00002510
|
10957 | PNRC1, B4-2, PNAS-145, PROL2, PRR2 | proline-rich nuclear receptor coactivator 1 |
C00002510
|
55684 | RABL6, C9orf86, PARF, RBEL1, pp8875 | RAB, member RAS oncogene family-like 6 |
C00002510
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002510
|
55183 | RIF1 | RAP1 interacting factor homolog (yeast) |
C00002510
|
285367 | RPUSD3 | RNA pseudouridylate synthase domain containing 3 |
C00002510
|
6455 | SH3GL1, CNSA1, EEN, SH3D2B, SH3P8 | SH3-domain GRB2-like 1 |
C00002510
|
5250 | SLC25A3, PHC, PTP | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 |
C00002510
|
6426 | SRSF1, ASF, SF2, SF2p33, SFRS1, SRp30a | serine/arginine-rich splicing factor 1 |
C00002510
|
84222 | TMEM191A, TMEM191AP | transmembrane protein 191A (pseudogene) |
C00002510
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002510
|
203068 | TUBB, M40, OK/SW-cl.56, TUBB1, TUBB5 | tubulin, beta class I |
C00002510
|
7322 | UBE2D2, E2(17)KB2, PUBC1, UBC4, UBC4/5, UBCH5B | ubiquitin-conjugating enzyme E2D 2 (EC:6.3.2.19) |
C00002510
|
84159 | ARID5B, DESRT, MRF-2, MRF2 | AT rich interactive domain 5B (MRF1-like) |
C00002510
|
501 | ALDH7A1, ATQ1, EPD, PDE | aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) |
C00002510
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00002510
|
375790 | AGRN | agrin |
C00002510
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00002510
|
54663 | WDR74 | WD repeat domain 74 |
C00002510
|
80014 | WWC2, BOMB | WW and C2 domain containing 2 |
C00002510
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00004579
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00004579
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00004579
|
1000 | CDH2, CD325, CDHN, CDw325, NCAD | cadherin 2, type 1, N-cadherin (neuronal) |
C00002510
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00004579
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00004579
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00004579
|
891 | CCNB1, CCNB | cyclin B1 |
C00004579
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00004579
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00004579
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004579
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00004579
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00004579
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00004579
|
3596 | IL13, IL-13, P600 | interleukin 13 |
C00004579
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00004579
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004579
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004579
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00004579
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00004579
|
354 | KLK3, APS, KLK2A1, PSA, hK3 | kallikrein-related peptidase 3 (EC:3.4.21.77) |
C00004579
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00004579
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00004579
|
4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00004579
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00004579
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00004579
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00004579
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#613985 | Beta-thalassemia |
P68871
|
#603902 | Beta-thalassemia, dominant inclusion body type |
P68871
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#140700 | Heinz body anemias |
P68871
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#211980 | Lung cancer |
P00533
P04637 |
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180849 | Rubinstein-taybi syndrome 1; rsts1 |
Q92793
|
#603903 | Sickle cell anemia |
P68871
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) |
H00018 | Gastric cancer |
P00533
(related)
P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04637 (related) P68871 (marker) |
H00028 | Choriocarcinoma |
P00533
(related)
P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
|
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) P68871 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00228 | Thalassemia |
P68871
(related)
|
H00229 | Sickle cell anemia (SCA) |
P68871
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q92793
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|